Evidence map›Paper›PMID 29504491›Full record

ArticleThe journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians2019

Unbound bilirubin measurements by a novel probe in preterm infants.

Thomas Hegyi, Alan Kleinfeld, Andrew Huber, Barry Weinberger, Naureen Memon, Weichung Shih, Mary Carayannopoulos, William Oh

Open access · greenAbstract readValidation Study
In one paragraph

Article in The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 14 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Bilirubin Encephalopathy.Current neurology and neuroscience reports · 2022
    Review
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 1 country.

Thomas Hegyia Rutgers Robert Wood Johnson Medical School New Brunswick , New Brunswick , NJ , USA.ORCID http://orcid.org/0000-0001-9919-1043
Alan Kleinfeldb Fluoresprobe Sciences , San Diego , CA , USA.
Andrew Huberb Fluoresprobe Sciences , San Diego , CA , USA.
Barry Weinbergerc Department of Pediatrics , Cohen Children's Medical Center Division of Neonatology , New Hyde Park , NY , USA.
Naureen Memond Morristown Memorial Hospital , Morristown , NJ , USA.
Weichung Shihe Rutgers School of Public Health , Piscataway , NJ , USA.
Mary Carayannopoulosf Rutgers Robert Wood Johnson Medical School , Piscataway , NJ , USA.
William Ohg Brown University Warren Alpert Medical School , Providence , RI , USA.
Rutgers, The State University of New Jersey · USFluoresprobe Sciences (United States) · USBrown University · USCohen Children's Medical Center · USMorristown Medical Center · US

Funding

Device for measuring blood concentrations of unbound bilirubin in neonatesR44HD080412 · NICHD · FLUORESPROBE SCIENCES, LLC · PI KLEINFELD, ALAN MARC · 2014 to 2020
$4.2M
Unbound fatty acids, Intralipid and Unbound Bilirubin in Preterm InfantsR03HD077422 · NICHD · RBHS-ROBERT WOOD JOHNSON MEDICAL SCHOOL · PI HEGYI, THOMAS · 2014 to 2015
$157k
NICHD NIH HHS R03 HD077422NICHD NIH HHS R44 HD080412
6 · The paper itself

Abstract

backgroundHyperbilirubinemia occurs in over 80% of newborns and severe bilirubin toxicity can lead to neurological dysfunction and death, especially in preterm infants. Currently, the risk of bilirubin toxicity is assessed by measuring the levels of total serum bilirubin (TSB), which are used to direct treatments including immunoglobulin administration, phototherapy, and exchange transfusion. However, free, unbound bilirubin levels (Bf) predict the risk of bilirubin neurotoxicity more accurately than TSB.

objectiveTo examine Bf levels in preterm infants and determine the frequency with which they exceed reported neurotoxic thresholds.

methodsOne hundred thirty preterm infants (BW 500-2000 g; GA 23-34 weeks) were enrolled and Bf levels measured during the first week of life by the fluorescent Bf sensor BL22P1B11-Rh. TSB and plasma albumin were measured by standard techniques. Bilirubin-albumin dissociation constants (K

resultsFive hundred eighty samples were measured during the first week of life, with an overall mean Bf of 13.6 ± 9.0 nM. A substantial number of measurements exceeded potential toxic thresholds levels as reported in the literature. The correlation between Bf and TSB was statistically significant (r

conclusionsUnbound (free) bilirubin values are extremely variable during the first week of life in preterm infants. A significant proportion of these values exceeded reported neurotoxic thresholds.

Indexed as

BilirubinFemaleGestational AgeHearing LossHearing TestsHumansHyperbilirubinemia, NeonatalInfant, Extremely Low Birth WeightInfant, Extremely PrematureInfant, NewbornMalePredictive Value of TestsSerum AlbuminBilirubinSerum Albuminhearingpremature infantUnbound bilirubin

Identifiers

PMID29504491
PMCPMC6135709
OpenAlexW2789851062

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.